• PNS16 Capturing the Complexity of Medicare's Pharmacy Benefit Structure in a Budget Impact Model

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PIN5 Immunogenicity and Safety of the COVID-19 Vaccines Compared to Controls in Healthy Adults: A Systematic Review

    Jun 1, 2021, 00:00

  • PMD3 The Current Burden of Cataract Surgery and Outcomes of Image-Guided Systems: A Targeted Literature Review

    Jun 1, 2021, 00:00

  • PCN21 A Real-World Assessment of the Treatment Patterns, Healthcare Resource Utilization (HCRU) and Outcomes Associated with Gastric Cancer (GC) and Gastroesophageal Junction Cancer (GEJC) in the United States

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PDG41 Evaluating the Effectiveness and Safety and Economy of Domestic and Original Tigecycline for Injection in Real-World Based on PSM Method

    Jun 1, 2021, 00:00

  • PMH12 To Evaluate the Overall Clinical and Economic Burden of Treatment Resistant Depression in Egypt from the Payers Perspective

    Jun 1, 2021, 00:00

  • PMU41 Clinical Pharmacy Provider Dashboards May Prevent Avoidable Adverse Events and Reduce Total Cost of Care

    Jun 1, 2021, 00:00

  • PRO66 Health-Related Quality of Life in Persons with Sickle Cell Disease

    Jun 1, 2021, 00:00

  • PUK9 Economic Evaluation of Prostate-Specific Antigen Screening for Prostate Cancer in China

    Jun 1, 2021, 00:00

  • Neurological Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • EM4 Recommendations for Handling Uncertainty in Economic Evaluation: A Targeted Review of Pharmacoeconomic Guidelines

    Jun 1, 2021, 00:00

  • Alternative Medicine Public Health

    Jun 1, 2021, 00:00

  • PIH15 Antimuscarinic Cascade across Individual Cholinesterase Inhibitors in Older Adults with Dementia

    Jun 1, 2021, 00:00

  • PCN99 Healthcare Costs for Elderly Patients with Lung Cancer and Comorbid Major Depressive Disorder (MDD)

    Jun 1, 2021, 00:00

  • PRO24 Healthcare Utilization and Costs Among Patients Diagnosed with Sickle Cell Disease Enrolled in Mississippi Medicaid

    Jun 1, 2021, 00:00

  • PMU59 Predictors and Health Related Quality of Life Associated with Renal Diseases in Cancer Patients in United States

    Jun 1, 2021, 00:00

  • EC4 Real-World Healthcare Costs in Patients with Classical Hodgkin Lymphoma Treated with Pembrolizumab and Nivolumab in the United States

    Jun 1, 2021, 00:00

  • PCN146 Association of Health Related Quality of Life with Breast Cancer Survival Among Hispanic Population Using Medical Expenditure Panel Survey DATA (2006-2015)

    Jun 1, 2021, 00:00

  • PMD4 Patient-Specific Factors Impacting the Reduction in Pain or Pain Medication Utilization After Treatment with Intra-Articular Hyaluronic Acid in Knee Osteoarthritis: A Retrospective Cohort Study

    Jun 1, 2021, 00:00

  • PCN244 Supervised Machine Learning for Predicting Mortality in Acute Myeloid Leukemia Patients Using Electronic Health Record Data

    Jun 1, 2021, 00:00

  • Musculoskeletal Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PUK11 Comparison of Hospitalization Burden of Hyperkalemia in Medicaid Patients By Ethnicity: A Propensity Score Matched Analysis of in-Patient Claims Database

    Jun 1, 2021, 00:00

  • Neurological Disorders - Organizational Practices

    Jun 1, 2021, 00:00

  • Economic Evaluation of New Models of Care: Does the Decision Change Between Cost-Utility Analysis and Multi-Criteria Decision Analysis?

    Jun 1, 2021, 00:00

  • Individual's Health - Patient-Centered Research

    Jun 1, 2021, 00:00

  • Multiple Diseases - Organizational Practices

    Jun 1, 2021, 00:00

  • PIH36 How Does Caregiver Burden Change As Alzheimer's Dementia (AD) Severity Advances?

    Jun 1, 2021, 00:00

  • PCN205 IMPACT of Treatment Adherence on CORE Outcomes in Patients with Colorectal Cancer: A Systematic Review

    Jun 1, 2021, 00:00

  • PCN71 Treatment-Related Costs of Pharmacologic Regimens for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Who Have Received Two or More Prior Lines of Therapies

    Jun 1, 2021, 00:00

  • PIN49 Developing a Predictive Algorithm to Identify the Key Factors Impacting on the Transmission and Fatalities from COVID-19

    Jun 1, 2021, 00:00

  • PND36 Budget Impact Analysis of the Incorporation of Mechanical Thrombectomy with Stent Retrievers after Thrombolysis in Ischemic-Stroke with Large Vessel Occlusion in Programa De Atencion medica Integral Pami in Argentina

    Jun 1, 2021, 00:00

  • PIN67 Real-Time Analysis of COVID-19 DATA Using Sequential Monte Carlo Methods

    Jun 1, 2021, 00:00

  • PMU38 Market Access Trends of Pharmaceutical Products in the EU5 and US (2009-2019)

    Jun 1, 2021, 00:00

  • PMU64 Impact Of The First Demonstration of a Patient-Centered Medical Home (PCMH) In Singapore On Quality Of Life And Patient Activation In Older Adults

    Jun 1, 2021, 00:00

  • PSS17 Long- and Short-Term Disability and Workers' Compensation Trends for Employees with Eye (Ophthalmic) Conditions in the United States

    Jun 1, 2021, 00:00

  • PCN7 Analysis of Individual-Level Association of Progression-Free Survival (PFS) and Time to Treatment Failure (TTF) with Overall Survival (OS) for Previously Untreated Advanced Renal Cell Carcinoma Patients in the CheckMate 214 Trial

    Jun 1, 2021, 00:00

  • PNS17 Value of a Comprehensive Ophthalmology Custom Pack in a Canadian Setting

    Jun 1, 2021, 00:00

  • Sensory System Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PNS104 Findings from the 2020 Ispor Student Benefit Survey

    Jun 1, 2021, 00:00

  • PNS9 Estimating Incidence Progressed Patients in Partitioned Survival Models - a Comparison of Three Methodologies

    Jun 1, 2021, 00:00

  • Medical Technology Studies

    Jun 1, 2021, 00:00

  • PRS3 Joint Modelling of Forced Vital Capacity Decline and Time to Hospitalization Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease

    Jun 1, 2021, 00:00

  • PMU5 IMPACT of Telehealth Utilization during the COVID-19 Pandemic on Health Care Resource Utilization

    Jun 1, 2021, 00:00

  • PRS15 A Cost-Utility Analysis of Dacomitinib As First-Line Treatment for Patients with Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 21 L858R Substitution Mutation in China

    Jun 1, 2021, 00:00

  • Cancer - Health Technology Assessment

    Jun 1, 2021, 00:00

  • PIN35 Prevalence of COVID-19 vs. Seasonal Influenza: A Population-Based National Survey of US Adults

    Jun 1, 2021, 00:00

  • PCN182 A Partial Mcda Approach to Identify Key Criteria for Brazilian Public Reimbursement Decision in Melanoma Adjuvant Treatment Setting

    Jun 1, 2021, 00:00

  • PIN43 Sociodemographic Characteristics Associated with Vaccination for Dengue Fever and Yellow Fever in Brazil: Results from the 2018 National Health and Wellness Survey

    Jun 1, 2021, 00:00

  • Cancer - Medical Technologies

    Jun 1, 2021, 00:00

  • Medical Devices - Medical Technologies

    Jun 1, 2021, 00:00

  • Musculoskeletal Disorders - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • Surgery - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PMU8 The Economic Burden of Thromboembolic Events Among Patients with Immune-Mediated Diseases

    Jun 1, 2021, 00:00

  • PND22 Cost-Utility of Mechanical Thrombectomy after Thrombolysis in Ischemic-Stroke Due to Large Vessel Oclussion in Obras Sociales and Empresas De Medicina Prepaga in Argentina

    Jun 1, 2021, 00:00

  • PDG27 A Systematic Review of Concomitant Opioid and Sedative or Skeletal Muscle Relaxant Use on Patient Outcomes in Chronic Non-Malignant Pain

    Jun 1, 2021, 00:00

  • Mental Health - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PCV48 Clinical Restrictions in Cardiac Health Technology Assessments

    Jun 1, 2021, 00:00

  • PCN184 Understanding the VALUE of Real-World Evidence (RWE) in Health Economics: Are Traditional Systematic Literature Reviews (SLRS) Omitting Key Evidence for Health Technology Assessment (HTA)?

    Jun 1, 2021, 00:00

  • IN3 Economic VALUE and Health System IMPACT of Remdesivir in Treating Hospitalized COVID-19 Patients in the United States

    Jun 1, 2021, 00:00

  • PMD2 Laparoscopic Radiofrequency Ablation VS Laparoscopic Myomectomy in the Treatment of Symptomatic Uterine Leiomyomas: A Meta-Analysis of Randomized Controlled Trials

    Jun 1, 2021, 00:00

  • PNS118 Real World Evidence (RWE) Use in Latin America Healthcare Decision Making: An Stakeholder Survey Analysis.

    Jun 1, 2021, 00:00

  • PND7 Assessing the Comparative Efficacy of INP104 for Acute Treatment of Migraine Attacks: A Matching-Adjusted Indirect Comparison

    Jun 1, 2021, 00:00

  • PND54 A Comparison of NOS and ROBINS-I Tools for Quality Assessment of Observational Studies

    Jun 1, 2021, 00:00

  • Infectious Diseases - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PNS2 Does the Type of Device Affect Usability or Conceptual Understanding of Patient-Reported Outcomes? Qualitative Evidence and Implications for Bring-Your-Own-Device (BYOD)

    Jun 1, 2021, 00:00

  • PMS23 Preferences of Patients with Rheumatoid Arthritis Are Diverse and Changeable

    Jun 1, 2021, 00:00

  • PRS14 Evolution of Direct Medical Costs Associated with Respiratory Syncytial VIRUS Disease in Infants: A Retrospective Database Analysis from 2008 to 2017

    Jun 1, 2021, 00:00

  • PCN136 Evaluation of the Extent of Real-World Evidence (RWE) Used Within Health Technology Appraisals (HTA) in Oncology: A Comparative Study of Six HTA Agencies

    Jun 1, 2021, 00:00

  • PNS45 Pricing and Reimbursement of Innovative Medicines: Challenges and Lessons from South-Eastern Europe

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • AI4 Comparing Machine-Learning Methods for the Prediction of Major Adverse Limb Events and Mortality after a Percutaneous Intervention

    Jun 1, 2021, 00:00

  • PUK8 Water: A Prevention Strategy to Decrease the Economic Burden of Recurrent Cystitis Among Women in the United States of America

    Jun 1, 2021, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • MT3 Assessing the Potential Value of Wearable Digital Health Technologies in Chronic Kidney Disease Using Early HTA Methods

    Jun 1, 2021, 00:00

  • PCV14 Examining the Direct and Indirect Healthcare Cost Among Pulmonary Arterial Hypertension Patients

    Jun 1, 2021, 00:00

  • PRO73 Limitations of Matched Control Groups Using Stabilization Criteria: A Case Study in CAH

    Jun 1, 2021, 00:00

  • PCN193 Assessing the Impact of Modeling Non-Disease-Related Mortality on Long-Term Survivorship Rates in Previously Untreated Advanced Melanoma: A Case Study from CheckMate 067

    Jun 1, 2021, 00:00

  • PMS3 Risk Factors Associated with Falls and Fractures Followed by Opioid Prescription among Privately-Insured Patients with Osteoarthritis

    Jun 1, 2021, 00:00

  • PIH25 Comparative Effectiveness Analysis of a Pediatric Co-Management Program

    Jun 1, 2021, 00:00

  • PCN232 Economic Burden Among Breast Cancer Patients in the United States

    Jun 1, 2021, 00:00

  • PBI13 Cost-Minimization Analysis and Budget Impact of Upadacitinib in the Treatment of Rheumatoid Arthritis in the Brazilian Public Health System

    Jun 1, 2021, 00:00

  • PRO28 Healthcare Resource Use (HCRU) of Patients with Aromatic L-Amino Acid Decarboxylase Deficiency (AADC-D) in France

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PCN109 Disease Burden of Metastatic Hormone-Sensitive Prostate Cancer (MHSPC) in China

    Jun 1, 2021, 00:00

  • IN2 Characteristics of Patients Diagnosed with Coronavirus Disease 2019 (COVID-19) across the Three Waves in the US: A Claims-Based Study Using a Large National Sample

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PRO29 Cost-Effectiveness Analysis of Using Hypoxic Stored Red Blood Cells to Reduce the Frequency of Blood Transfusions

    Jun 1, 2021, 00:00

  • PR2 Concordance of Preferences and Treatment Choice Using Choice Based Adaptive Conjoint Analysis

    Jun 1, 2021, 00:00

  • PNS27 Amphetamine-Related Hospitalizations in the United States, 2003-2014: Examining Trends and Factors Associated with Admission Outcomes

    Jun 1, 2021, 00:00

  • Drugs Generics - Health Technology Assessment

    Jun 1, 2021, 00:00

  • Mental Health - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • ED4 Economic Burden of Attention-Deficit/Hyperactivity Disorder (ADHD) Among Children and Adolescents in the United States (US): A Societal Perspective

    Jun 1, 2021, 00:00

  • PUK10 Cost–Utility Analysis of DyeVert Contrast Reduction Systems for Preventing Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary and/or Peripheral Angiography

    Jun 1, 2021, 00:00

  • PRO21 Burden of Illness in Patients with Light Chain (AL) Amyloidosis: A Real World Study Using Optum Claims Database

    Jun 1, 2021, 00:00

  • PIN21 The Cost-Utility of Remote Pulse-Oximeter Monitoring of COVID19 Patients

    Jun 1, 2021, 00:00

  • Infectious Diseases - Economic Evaluation

    Jun 1, 2021, 00:00

  • PCV31 Cost-Effectiveness of Dronedarone for the Treatment of Atrial Fibrillation in China

    Jun 1, 2021, 00:00

  • PCN107 Economic Burden of Complications Associated with Transthoracic Needle Biopsy of Pulmonary Nodules: A Retrospective Cohort Analysis

    Jun 1, 2021, 00:00

  • PRO35 Characterization and Treatment of Immune Thrombocytopenia (ITP) in Europe: A Qualitative Observational Study

    Jun 1, 2021, 00:00

  • PMU25 Computable Phenotypes (CPS) for Identifying Individuals with MULTI-Morbidity from Real-World DATA (RWD): A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PCN211 Health-Related Quality of Life in DLBCL Patients Treated with CAR T-Cell Therapy:

    Jun 1, 2021, 00:00

  • PNS22 Real-World DATA of ADR Reports in Signal Detection - DME Perspective

    Jun 1, 2021, 00:00

  • PRO18 A Systematic Literature Review of the Economic Burden and Cost Drivers in Pulmonary Arterial Hypertension

    Jun 1, 2021, 00:00

  • PRO56 Psychometric Validation of the Short-Form 36 (version 2) (SF-36) in Tumor-Induced Osteomalacia (TIO)

    Jun 1, 2021, 00:00

  • PMU31 An Assessment of the Relationship Between Depression and Treatment Satisfaction Among Saudi Acne Vulgaris Patients Using Expectation–Confirmation Theory

    Jun 1, 2021, 00:00

  • PRO48 Utilities in a rare disease collected via vignettes in general population samples from the UK and Fran comparison of Results

    Jun 1, 2021, 00:00

  • PMS26 Decision-Making and Experienced Benefits and Risks of Corticosteroids As a Treatment for Duchenne Muscular Dystrophy

    Jun 1, 2021, 00:00

  • Neurological Disorders - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PCN32 Comparative Efficacy of Combination of Dabrafenib and Trametinib Against Other Adjuvant Therapies for Melanoma

    Jun 1, 2021, 00:00

  • PND63 Patient Utilities in Parkinson's Disease in Health States Based on Hoehn and Yahr and Off-Time

    Jun 1, 2021, 00:00

  • PCN237 Patterns of Healthcare Resource Utilization (HRU) in Unfit Patients with Acute Myeloid Leukemia (AML) Receiving First-line Systemic Treatment or Best Supportive Care (BSC): A Multicenter International Study (CURRENT)

    Jun 1, 2021, 00:00

  • PRO47 Understanding the Burden of Long-Chain Fatty Acid Oxidation Disorders for Patients and Caregivers

    Jun 1, 2021, 00:00

  • PSU9 A Cost-Consequence MODEL of Surgical Nutrition for TOTAL Knee Arthroplasty

    Jun 1, 2021, 00:00

  • PSU6 Cost-Eectiveness Analysis of the Application of Porcine-Derived Fibrin Sealant for the Treatment of IntraOperative Cerebrospinal Fluid Leak in China

    Jun 1, 2021, 00:00

  • HT3 What is Value? A Systematic Review of Value Assessment Frameworks

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PCV22 Estimating the Reduction in Medical Care Costs Associated with Ticagrelor and Aspirin in Patients with Acute Ischemic Stroke or TIA

    Jun 1, 2021, 00:00

  • Does Cost-Effectiveness Analysis Overvalue Potential Cures? Exploring Alternative Methods for Applying a “Shared Savings” Approach to Cost Offsets [Editor's Choice]

    Jun 1, 2021, 00:00

  • PND61 Caregiver-Reported Outcomes in Alzheimer's Disease and Other Dementias: A Survey of Interventional Clinical Trials of Pharmacologic Therapies

    Jun 1, 2021, 00:00

  • PNS95 Valuation of Preference-Based Measures: Could Borrowing Strength from Existing Countries' Valuations Produce Better Estimates

    Jun 1, 2021, 00:00

  • Infectious Diseases - Health Technology Assessment

    Jun 1, 2021, 00:00

  • IN4 Non-Health Considerations in Economic Evaluations of COVID-19 Interventions: A Systemic Review

    Jun 1, 2021, 00:00

  • Neurological Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PCN150 Barriers to and Facilitators of Cervical Cancer Screening Among Women in Southeast Asia: a Systematic Review

    Jun 1, 2021, 00:00

  • No Specific Disease - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCN231 Humanistic and Economic Burden in Patients with Chronic Myeloid Leukemia – A Review of the Literature

    Jun 1, 2021, 00:00

  • No Specific Disease - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PRO30 The Cost-Effectiveness of OTL-200 for the Treatment of Metachromatic Leukodystrophy (MLD)

    Jun 1, 2021, 00:00

  • PSY11 Systematic Literature Review to Assess Overall Costs and Societal Impacts of Atopic Dermatitis in Europe

    Jun 1, 2021, 00:00

  • PCN82 Cost-Effectiveness of Once Weekly Selinexor-Bortezomib-Dexamethasone (XVD) in Previously Treated Multiple Myeloma (MM)

    Jun 1, 2021, 00:00

  • PCN12 A Systematic Literature Review (SLR) of Clinical Outcomes of Treatments for Adult and Pediatric Relapsed/Refractory (R/R) Classical Hodgkin's Lymphoma (cHL) Patients in the UK

    Jun 1, 2021, 00:00

  • PCN34 Comparative Effectiveness of Docetaxel and Paclitaxel in Advanced Esophageal Squamous Cell Carcinoma Refractory or Intolerant to Previous Chemotherapy: Propensity Score-Matching Analyses from Attraction-3 Trial

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCN15 Increasing Disease Complexity Poses Challenges for Indirect Treatment Comparisons: An Example in Relapsed and Refractory Multiple Myeloma (RRMM)

    Jun 1, 2021, 00:00

  • PMH19 Evaluation of Symptoms of Depression Amongst People with Substance Use during COVID-19 Lockdown in India: A CROSS-Sectional Study

    Jun 1, 2021, 00:00

  • PCV4 Comorbidities and Survival Risk Measures of Pulmonary Hypertension (PH) Patients in US-Clinical Care: Real-World Assessments from the Trio Health PH Registry

    Jun 1, 2021, 00:00

  • PCN139 Value Frameworks and Innovative Contracting for Comprehensive Genomic Profiling

    Jun 1, 2021, 00:00

  • The Use of Decision Analytic Modeling in the Evaluation of Surgical Innovations: A Scoping Review

    Jun 1, 2021, 00:00

  • PCN52 Cost-Effectiveness Analysis of the Third-LINE Treatment of Regorafenib for Metastatic or Unresectable Gastrointestinal Stromal Tumors in China

    Jun 1, 2021, 00:00

  • PCV9 Budget IMPACT Analysis of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event in the United States

    Jun 1, 2021, 00:00

  • PMU19 Comparison of Burden of Hospitalizations in Rheumatoid Arthritis (RA), Crohns Disease (CD) and Ulcerative Colitis (CD) Patients Insured By Medicaid: A Propensity Score Matched Analysis of in-Patient Claims Database

    Jun 1, 2021, 00:00

  • PRO65 Engaging Patients in Drug Development for Regulatory and HTA Decisions: A Case Study in Patients with Hidradenitis Suppurativa

    Jun 1, 2021, 00:00

  • PCN202 Use of Restricted Mean Survival Time in the Presence of Non-Proportional Hazards As an Alternative Measure of Treatment Benefit in Cost-Effectiveness Analyses

    Jun 1, 2021, 00:00

  • PND4 Real World Evidence to Support the Clinical Effectiveness of Multiple Sclerosis Therapies: A US Perspective

    Jun 1, 2021, 00:00

  • CE2 Effect of Different Variance Estimation Methods with Inverse Probability Treatment Weights (IPTW) on Comparative Effectiveness Measure in Multiple Sclerosis

    Jun 1, 2021, 00:00

  • Injury Trauma - Economic Evaluation

    Jun 1, 2021, 00:00

  • Machine Learning Applications in Health

    Jun 1, 2021, 00:00

  • PIN53 Factors that Predispose Individuals to Influenza Virus Infections: A Claims-Based Case-Control Study

    Jun 1, 2021, 00:00

  • PND51 Trends and Characteristics in Opioid Analgesic Use for Migraine in US Emergency Departments: Analysis of National Hospital Ambulatory Medical Care Survey 2007-2018 Data

    Jun 1, 2021, 00:00

  • PNS52 Examining US Commercial Health Plans' Use of Step Therapy Protocols for Specialty Drugs: An Empirical Analysis

    Jun 1, 2021, 00:00

  • PCN213 Systematic Literature Review to Characterize the Burden and Unmet Needs Associated with Cremophor EL

    Jun 1, 2021, 00:00

  • PCN11 The potential long-term comparative effectiveness of larotrectinib vs. lenvatinib or sorafenib for treatment of NTRK fusion-positive metastatic thyroid cancer

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PCN40 Economic and Clinical Burdens of Recurrence Following Nephrectomy for Intermediate-High or High-Risk Renal Cell Carcinoma (RCC): A Retrospective Administrative Claims Analysis

    Jun 1, 2021, 00:00

  • PIN31 Budget-IMPACT Analysis of Letermovir for Preventing Cytomegalovirus in Adult Cytomegalovirus Seropositive Allogeneic Hematopoietic Cell Transplant Recipients in the United States

    Jun 1, 2021, 00:00

  • PRO74 Pilot Study of a Novel Patient-facing Medical Records Collection Platform to Support Real World Data Generation in Rare Disease

    Jun 1, 2021, 00:00

  • PRS19 Trends in Diagnostic Prevalence, Treatment Patterns, and Healthcare Resource Utilization of Adult Patients with Food Allergies in the United States, 2008-2018

    Jun 1, 2021, 00:00

  • PMH53 A Machine Learning Approach to Understanding How Patient Engagement with a Prescription Digital Therapeutic Relates to Healthcare Resource Utilization in Opioid Use Disorder

    Jun 1, 2021, 00:00

  • Medical Devices - Patient-Centered Research

    Jun 1, 2021, 00:00

  • Multiple Diseases - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PDG36 Predicting Opioid Use Disorder Using Machine Learning Methodologies

    Jun 1, 2021, 00:00

  • PIN23 Costs-Consequences Analysis of Ceftaroline Fosamil for the Treatment of Community-Acquired Pneumonia in the Brazilian Private Healthcare System

    Jun 1, 2021, 00:00

  • PMU62 Improved Quality of Life in Children With Progressive Familial Intrahepatic Cholestasis Following 24 Weeks of Treatment With Odevixibat, an Ileal Bile Acid Transporter Inhibitor: Results From the Phase 3 PEDFIC 1 Study

    Jun 1, 2021, 00:00

  • PIT4 In-HOME IV Antibiotics Cost and Utilization Following Tibia Fractures

    Jun 1, 2021, 00:00

  • Cancer - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PND58 Health-Related Quality of Life and Caregiver Burden for Caregivers of Individuals with Neurogenic Orthostatic Hypotension

    Jun 1, 2021, 00:00

  • PCN170 Can Early U.S. Adoption of Cancer Drugs Inform HTA Decision-Making?

    Jun 1, 2021, 00:00

  • Cost-Effectiveness Modeling of Surgery Plus Adjuvant Endocrine Therapy Versus Primary Endocrine Therapy Alone in UK Women Aged 70 and Over With Early Breast Cancer

    Jun 1, 2021, 00:00

  • PND21 A Tool Proposal For Measuring Costs Using Time-Driven Activity-Based Costing For The Ischemic Stroke Care Pathway

    Jun 1, 2021, 00:00

  • PMU48 The IMPACT of COVID-19 on European Health Technology Assessments

    Jun 1, 2021, 00:00

  • RE3 Expectations Versus Reality: How Real-World Data Fits into Budget Impact Analyses

    Jun 1, 2021, 00:00

  • RE4 The IMPACT of Reimbursement for NON-Face-to-Face Chronic Care Management on Health Outcomes and Health Care Utilization Among Patients with Type 2 Diabetes in Louisiana

    Jun 1, 2021, 00:00

  • PGI3 A Network Meta-Analysis to Compare Efficacy of Filgotinib with Other Treatments in Biologic-Naïve Patients with Moderately to Severely Active Ulcerative Colitis

    Jun 1, 2021, 00:00

  • PCN125 Waste of Resources in Cervical and Breast Cancer Screening in JAPAN

    Jun 1, 2021, 00:00

  • PND30 Resource Use at Different Levels of Severity of Parkinson's Disease in a Swedish Setting

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PRS27 A Systematic Review on the Impact of Digital Health Technologies in Latent Tuberculosis Infection Management

    Jun 1, 2021, 00:00

  • PMH13 Healthcare Resource Utilization and Costs before and after Long-Acting Injectable Antipsychotic (LAI) Use in Commercially Insured Young Adults with Schizophrenia

    Jun 1, 2021, 00:00

  • Surgery - Medical Technologies

    Jun 1, 2021, 00:00

  • PCV34 Cost-Offset Analysis of Dapagliflozin in Treating Heart Failure with Reduced Ejection Fraction (HFREF) in China

    Jun 1, 2021, 00:00

  • PND31 Comparison of Burden of Hospitalizations in Epilepsy, Migraine and Sleep Disorders: A Propensity Score Matched Analysis of In-Patient Claims Database

    Jun 1, 2021, 00:00

  • PND35 Modeling The Economic Impact Of Incorporating AbobotulinumtoxinA Into An Institutional Formulary For FDA-Approved Indications

    Jun 1, 2021, 00:00

  • Copyright/Subscription

    Jun 1, 2021, 00:00

  • PCN75 Cost-Minimization and Budget Impact Analysis of Venetoclax plus Obinutuzumab versus Ibrutinib in High-Risk Patients with Untreated Chronic Lymphocytic Leukemia in the Brazilian Unified Health System (SUS)

    Jun 1, 2021, 00:00

  • PND26 The Cost-Effectiveness of Fremanezumab in Patients with Migraine Who Have Failed Two or More Previous Migraine Preventive Therapies From a UK Healthcare System Perspective

    Jun 1, 2021, 00:00

  • PMH23 Epidemiology of Acute Agitation Secondary to Schizophrenia and/or Bipolar Disorder in Patients Presenting to Emergency Departments, a Systematic Literature Review

    Jun 1, 2021, 00:00

  • PMS25 Patient-Reported Outcome Labeling for Rheumatoid Arthritis Drugs Approved in the United States: 2010-2019

    Jun 1, 2021, 00:00

  • PBI2 Real-World Evaluation of Biosimilar Bevacizumab-awwb versus Reference Bevacizumab in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer in a U.S. Integrated Healthcare Delivery System: 6-Month Interim Analysis

    Jun 1, 2021, 00:00

  • PMH11 Differences in Healthcare Expenditures of Older United States Adults with Self-Reported PAIN between Mental Health Status

    Jun 1, 2021, 00:00

  • PRS17 Economic Impact of COVID-19 Lockdown on Households in Nigeria

    Jun 1, 2021, 00:00

  • PIH34 Assessing the Understandability and Importance of Patient Reported Outcomes Impacting Adherence and Outcomes of a NON-Hormonal Vaginal Microbicide to Prevent and Protect Against Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (GC ...

    Jun 1, 2021, 00:00

  • PCN180 Is the Cancer Drugs Fund Functioning As Anticipated?

    Jun 1, 2021, 00:00

  • PSS18 Real-World Data Analysis of Dose Escalation and Associated Costs in Biologic Treatment of Psoriasis

    Jun 1, 2021, 00:00

  • PCN156 Real-World Non-Persistence with Oral Multiple Myeloma Treatments: A Comparative Analysis of Methodologies Using Claims Data

    Jun 1, 2021, 00:00

  • PIN72 Understanding Patient Experiences with Chronic Hepatitis B Virus (cHBV) and its Treatments

    Jun 1, 2021, 00:00

  • PMH26 Early Impact of COVID-19 Pandemic on Antipsychotic Medication Use Among Patients with Schizophrenia

    Jun 1, 2021, 00:00

  • Mental Health - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PIN61 Switch Patterns Among Patients Claiming Antifungal Therapies for Onychomycosis in Canada

    Jun 1, 2021, 00:00

  • PCN101 Real-World Economic Outcomes of First-Line (1L) Ibrutinib Treatment in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)

    Jun 1, 2021, 00:00

  • PMH8 Projecting the Economic Outcomes of Switching Patients with Schizophrenia from Oral Atypical Antipsychotics to Once-Monthly Paliperidone Palmitate and Once-Every-Three-Months Paliperidone Palmitate

    Jun 1, 2021, 00:00

  • PNS75 The Evolution of Payer Perceptions of Icer

    Jun 1, 2021, 00:00

  • PRO26 Cost of illness of Sickle Cell Disease in the US, Payer's Perspective: (CRESCENT).

    Jun 1, 2021, 00:00

  • PCN57 Cost-Effectiveness of Venetoclax in Combination with Obinutuzumab in First LINE Chronic Lymphocytic Leukemia in Colombia

    Jun 1, 2021, 00:00

  • PCN142 Patient and Caregiver Preferences in Treatment Decision Making in Multiple Myeloma — Results of a Targeted Literature Review

    Jun 1, 2021, 00:00

  • PNS7 Ongoing SLRs When Considering HTA Submissions: Rewards and Avoidable Pitfalls

    Jun 1, 2021, 00:00

  • Drugs Process of Care

    Jun 1, 2021, 00:00

  • PDB26 Applying the Stages of Implementation Completion (SIC) Framework Retrospectively to a Community Pharmacy Clinical Intervention Implementation Project for Scaling up Future Success

    Jun 1, 2021, 00:00

  • PCN70 Healthcare Resource Utilization and Costs Among Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Anaplastic Lymphoma Kinase (ALK) Inhibitors

    Jun 1, 2021, 00:00

  • PCN181 Real-World Evidence (RWE) in Reimbursement, Pricing, and Health Technology Assessment (HTA) in ASIA. How CAN Rwe Supplement Trial DATA in Oncology Indications in a Premarketing Setting?

    Jun 1, 2021, 00:00

  • PPM6 Evaluating an Artificial Intelligence Powered Medication Adherence Program's Targeting by Patients' Socially Vulnerability

    Jun 1, 2021, 00:00

  • PND34 Healthcare Utilization and Costs at End-of-Life Among US Medicaid Beneficiaries with Huntington's Disease

    Jun 1, 2021, 00:00

  • PNS8 Evaluating Social Media as a Data Source for Patient Experience Measures: A Study Protocol

    Jun 1, 2021, 00:00

  • PCN84 Comparing the Downstream Costs and Healthcare Utilization Associated with the Use of Low-dose Computed Tomography (LDCT) in Lung Cancer Screening in Patients with and without AlzheimerÂ’s Disease and Related Dementias (ADRD)

    Jun 1, 2021, 00:00

  • PMH20 Antimuscarinic Prescribing Cascade with Acetylcholinesterase Inhibitor Use Among a National Cohort of Older Adults with Alzheimer's Disease

    Jun 1, 2021, 00:00

  • PND69 Absence Benefit Utilization, Duration of Leaves, and Payments Vary By Benefit and over Time for Short- and Long-Term Disability and Workers' Compensation for Employees with Headaches and Migraines in the United States

    Jun 1, 2021, 00:00

  • PCN153 PhysiciansÂ’ Perceptions and Use of IDH1/2 Mutational Testing and Treatment Selection among Patients with Relapsed or Refractory Acute Myeloid Leukemia in Routine Clinical Practice

    Jun 1, 2021, 00:00

  • PDB29 Medication Non-Adherence and Health Literacy Among Medicare Beneficiaries with Type 2 Diabetes

    Jun 1, 2021, 00:00

  • Economic Evaluation in Oncology Studies

    Jun 1, 2021, 00:00

  • PSU21 Health Resource Utilization and Costs of Rectal Cancer Surgery in Korea

    Jun 1, 2021, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PCN240 Healthcare Resource Utilization Associated with Disease Recurrence Among Surgically-Treated Patients with Triple-Negative Breast Cancer

    Jun 1, 2021, 00:00

  • PCV15 Cost-Effectiveness of Screening for and Treating Masked Hypertension with out-of-Office Blood Pressure Monitoring

    Jun 1, 2021, 00:00

  • PRO64 Psychometric Validation of the Brief Fatigue Inventory (BFI) and Brief Pain Inventory Short-Form (BPI-SF) in Tumor-Induced Osteomalacia (TIO)

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • Sensory System Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • Expedited Partner Therapy for Sexually Transmitted Infections in Minnesota: A Mixed-Methods Review of Current Practices and Barriers to Implementation

    Jun 1, 2021, 00:00

  • PNS49 Are Multiple Brands Used to Charge Higher Prices for Orphan Drug Designations in the US?

    Jun 1, 2021, 00:00

  • PIH5 Healthcare Resource Utilization Associated with Prematurity: An Analysis of US Medicaid Data

    Jun 1, 2021, 00:00

  • PCN223 Recommendations For The Collection Of Patient-Reported Outcomes (PRO) Data In The Post-Progression And Post-Treatment Setting Following Oncology Clinical Trials

    Jun 1, 2021, 00:00

  • PCN224 Incorporating a Patient-Reported Symptom Burden Tool in Cancer Care Settings

    Jun 1, 2021, 00:00

  • PSY5 Comorbidity Related Excess Healthcare Expenditures Among Adults with Psoriasis in the United States: A Propensity Score Matched Analysis

    Jun 1, 2021, 00:00

  • PCN246 Trends in Prevalence, Treatment Patterns, Myelosuppression, and Burden on the Healthcare System Among Patients with Small Cell Lung Cancer: A SEER-Medicare Analysis

    Jun 1, 2021, 00:00

  • Surgery - Economic Evaluation

    Jun 1, 2021, 00:00

  • PSU3 The Impact of Operative Approach on Postoperative Outcomes and Health Care Utilization Following Colectomy

    Jun 1, 2021, 00:00

  • PND37 Cost-Effectiveness of BoNT-A Products for Treatment of Pediatric Spasticity in the United Kingdom

    Jun 1, 2021, 00:00

  • PIN15 Real-World Healthcare Costs of Patients Receiving Dolutegravir/Lamivudine and Other Single Tablet Regimens for the Treatment of HIV-1 in the US

    Jun 1, 2021, 00:00

  • Reviewer Acknowledgement

    Jun 1, 2021, 00:00

  • PMH9 Economic Burden of Major Depressive Disorder with Acute Suicidal Ideation or Behavior in the United States

    Jun 1, 2021, 00:00

  • PNS108 Psychometric Validation of New Scales Expanding Conceptual Coverage of the ABOUTTM-Perceived Risk: Perceived Social Risk and Perceived Practical Risk

    Jun 1, 2021, 00:00

  • PCN3 Changes in Transfusion Burden (TB), Hemoglobin (Hb), Serum Ferritin (SF), and Iron Chelation Therapy (ICT) Use in Patients With Lower-Risk Myelodysplastic Syndromes With Ring Sideroblasts Treated With Luspatercept From the MEDALIST Stu ...

    Jun 1, 2021, 00:00

  • Valuing Cures: Not If, But When? [Editor's Choice]

    Jun 1, 2021, 00:00

  • PCN126 Treatment Pattern and Cost Estimation of Melanoma in Brazilian Public Healthcare System

    Jun 1, 2021, 00:00

  • Infectious Diseases - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PCV3 Risk of Obstructive Sleep Apnea in Adults with Treatment Resistant Hypertension: A Population-Based Cohort Study

    Jun 1, 2021, 00:00

  • Surgery - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Real World Data Information Systems

    Jun 1, 2021, 00:00

  • PDG30 A Study on Adverse Drug Reaction Related Hospital Admissions of a Tertiary Care Hospital in South India

    Jun 1, 2021, 00:00

  • PCV23 Cost-Effectiveness of Dual Versus Triple Antithrombotic Therapy in Atrial Fibrillation and Recent PCI

    Jun 1, 2021, 00:00

  • PMD21 The Association of Major Adverse LIMB Events and Combination Stent and Atherectomy in Patients Undergoing Revascularization for Lower Extremity Peripheral Artery Disease

    Jun 1, 2021, 00:00

  • PDG40 Assessing the Tuscany Region Response to COVID-19 Lockdown in NON-Hospital Supply of Antidiabetic Drugs: An Interrupted Time Series Analysis

    Jun 1, 2021, 00:00

  • PBI7 Cost-Effectiveness Analysis of Adalimumab Biosimilar Compared to Delayed Biologic Treatment Initiation in Patients with Rheumatoid Arthritis in Germany

    Jun 1, 2021, 00:00

  • PRO14 Healthcare Resource Utilisation and Costs Saved with Earlier Diagnosis of Behcets Disease: Using UK Primary Care Electronic Health Records

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Economic Evaluation

    Jun 1, 2021, 00:00

  • Comparative Effectiveness Studies

    Jun 1, 2021, 00:00

  • PCN123 Hospital Admissions Associated with Cancer Pain and Dementia in Older Adults

    Jun 1, 2021, 00:00

  • PMH6 Healthcare Costs Increase Substantially Following Adjunctive Therapy Among MDD Patients on Antidepressant Monotherapy

    Jun 1, 2021, 00:00

  • Biologics/Biosimilars/Regenerative Medicine - Patient-Centered Research

    Jun 1, 2021, 00:00

  • RW3 Quantitative Bias Analysis (QBA) for Comparative Effectiveness of Alectinib versus Ceritinib in Non-Small Cell Lung Cancer (NSCLC)

    Jun 1, 2021, 00:00

  • PND70 Procedure Coding Versus Pharmacy-Dispensing Claims for Assessing Steroid Use in Patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) and Primary Immunodeficiency Diseases (PIDD)

    Jun 1, 2021, 00:00

  • PCN66 A Systematic Literature Review of the Economic Evaluations of Different Treatments in Patients with Chronic Myeloid Leukemia

    Jun 1, 2021, 00:00

  • EM3 Robustness of External Control Arm: WHEN to Use Them

    Jun 1, 2021, 00:00

  • PDB45 Continuous Glucose Monitoring (CGM) Trends Among US Adults with Type I Diabetes in National Health and Wellness Survey (NHWS)

    Jun 1, 2021, 00:00

  • PRS28 A Scoping Review of Consequences of Untreated Stroke: Economic Burden Due to COVID-19?

    Jun 1, 2021, 00:00

  • Drugs Generics - Economic Evaluation

    Jun 1, 2021, 00:00

  • PMH36 Think-Aloud Interviews in Health-Related Resource-Use Research: Application in the PECUNIA Project

    Jun 1, 2021, 00:00

  • PCN222 Health Related Quality of Life (HRQoL) Review in Patients with Ovarian Cancer: A Systematic Literature Review (SLR)

    Jun 1, 2021, 00:00

  • PNS41 Estimating Administrative Costs Linked to Medical Devices Recalls from the Perspective of the Healthcare Provider

    Jun 1, 2021, 00:00

  • No Specific Disease - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PPM5 The Application of Shared Decision Making in the Chronic Non-Cancer Pain Management: A Systematic Review

    Jun 1, 2021, 00:00

  • PIN55 Strategies, Ministers of Health and New Regulations: Did We Win or Were We Won By the COVID-19 Pandemic in Brazil?

    Jun 1, 2021, 00:00

  • Personalized Information Systems

    Jun 1, 2021, 00:00

  • Veterinary Medicine - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCN198 Statistical Methods for Pantumor Analysis: Models to Account for Tumor-Level Heterogeneity

    Jun 1, 2021, 00:00

  • PNS70 Societal Cost Savings Are Often Not Considered in NICE Decision Making

    Jun 1, 2021, 00:00

  • PB2 Real-World Adherence to Single-Inhaler Fluticasone Furoate/Umeclidinium/Vilanterol Versus Multiple-Inhaler Triple Therapy Among Asthma Patients in the US

    Jun 1, 2021, 00:00

  • PMD7 Budget Impact Analysis of Transcutaneous Afferent Patterned Stimulation Therapy for the Treatment of Essential Tremor in the United States

    Jun 1, 2021, 00:00

  • PCN249 Real World Treatment Patterns of Patients with Ovarian Cancer: Analysis of Targeted Therapies in the French National Claims Data

    Jun 1, 2021, 00:00

  • PIH19 Dosing and Safety of Medical Cannabis in Children: Preliminary Findings from a Living Systematic Review

    Jun 1, 2021, 00:00

  • PCN33 Real-World Progression-Free Survival by Timing of Molecular Profiling Testing Among Metastatic Non-Small Cell Lung Cancer Patients in a Community Setting

    Jun 1, 2021, 00:00

  • PNS69 Burnout Syndrome Prevention In Nursing At Pandemic (Covid-19): A Literature Review

    Jun 1, 2021, 00:00

  • PMH3 Effects of Antidepressants on Health-Related Quality of Life in Patients with Major Depressive Disorder; A Secondary Analysis Using Perform-J Study

    Jun 1, 2021, 00:00

  • PMU27 Association of Osteoarthritis to Incident Cancer among Adults in the United States

    Jun 1, 2021, 00:00

  • SM2 The Consequences of Greater Net Price Transparency for Innovative Medicines in Europe: Insights from a Multi-Agent Simulation Model

    Jun 1, 2021, 00:00

  • PCN129 Opioid Utilization in Cancer Survivors: A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PCN5 EARLY-Onset Colorectal Cancer in the United States: A Narrative Review of the Evidence

    Jun 1, 2021, 00:00

  • PNS59 Current Utilization and Perceptions of Value Assessment Frameworks Among United States Payers

    Jun 1, 2021, 00:00

  • PMS32 Prediction Models for Surgical Complications Following Total Knee Arthroplasty: Optum PAN-Therapeutic Electronic Health Records

    Jun 1, 2021, 00:00

  • Cardiovascular Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PCV28 Cost-effectiveness Analysis Of Viscoelastic Point-Of-Care Testing Versus Standard Laboratory Tests For Guiding Transfusion Therapy In Brazilian Patients Who Underwent Complex Cardiac Surgery

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Health Service Delivery Process of Care

    Jun 1, 2021, 00:00

  • PNS109 Reducing the Racial/Ethnic Disparities in Personal Health Record (PHR) Adoption in the US

    Jun 1, 2021, 00:00

  • PRO41 The Economic and Quality of Life impact of Entrectinib on CNS metastasis control

    Jun 1, 2021, 00:00

  • PCN44 Cost-Effectiveness of Durvalumab Following Chemoradiotherapy in Unresectable Stage III NSCLC Patients in the US: An Update Based on 4-Year Survival Data

    Jun 1, 2021, 00:00

  • PNS66 Stated Importance Versus Actual Impact: An Evaluation of HTA Practices to Incorporate Patient Perspectives in Value Assessments

    Jun 1, 2021, 00:00

  • PSY8 Calculating Indirect Costs Associated with Moderate and Severe Psoriasis in Russia

    Jun 1, 2021, 00:00

  • PRO25 Trend in Hospital Length of Stay, Costs and Comorbidities in Patients with Veno-Occlusive Disease (VOD): Analysis of National in-Patient Hospital Database

    Jun 1, 2021, 00:00

  • PRS7 Characteristics, Cost and Health Care Resource Use in a Population of Medicare Fee-for-Service (FFS) Patients with Chronic Obstructive Pulmonary Disease (COPD) Who Also Experience Pneumonia

    Jun 1, 2021, 00:00

  • PGI24 Complications and Healthcare Utilization in Adult Patients Receiving Parenteral Support for Intestinal Failure Associated with Short Bowel Syndrome

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PMH22 The Use of Naloxone in Opioid Overdose and Overdose at-Risk Populations: A Retrospective Medical Claims Analysis

    Jun 1, 2021, 00:00

  • PNS72 Charting the Progress of HTA in Asia: Are We Ready for Evidence Based Decision-Making?

    Jun 1, 2021, 00:00

  • PIN46 COVID-19 Patients Analysis Utilizing JAPAN and US Claims Databases

    Jun 1, 2021, 00:00

  • Injury Trauma - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PCN161 Continuity of Care, Health Resource Utilization, Cost and Mortality in Medicare Prostate Cancer Patients

    Jun 1, 2021, 00:00

  • CO3 Comparison of Goal Attainment and Measures of Function in Two Dementia Clinical Trials.

    Jun 1, 2021, 00:00

  • PDB40 Eliciting Patient Preferences for Continuous Glucose Monitoring Devices in Type 1 Diabetes

    Jun 1, 2021, 00:00

  • PRO22 Hospital Length of Stay, Total Costs and Comorbidities in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Analysis of National In-patient Hospital Database

    Jun 1, 2021, 00:00

  • PIN71 Influencing Factors and Economic Burden of Carbapenem Resistant Klebsiella Pneumoniae Pulmonary Infection in Neurosurgical Patients

    Jun 1, 2021, 00:00

  • PMU54 A Claims-Based Algorithm to Identify Inadequate Response to Immunomodulatory Therapies Among Patients with Selected Autoimmune Diseases

    Jun 1, 2021, 00:00

  • PMS12 Healthcare Costs and Insurance Coverage of Rheumatoid Arthritis Patients in the United States: A 2018 Medical Expenditure Panel Survey Data Analysis

    Jun 1, 2021, 00:00

  • PMU16 Hospital Outcomes Attributable to Congestive Heart Failure in Patients with Endometrial Cancer in the U.S.: A Retrospective Analysis

    Jun 1, 2021, 00:00

  • PCN78 A Set of Systematic and Targeted Reviews to Identify the Burden of Iron Chelation Therapy in Myelodysplastic Syndromes

    Jun 1, 2021, 00:00

  • PMD16 What Factors Do Clinicians Value Most in Selecting Physician Preference Items? a Survey in Orthopedics Using Discrete Choice Experiment and Best-Worst Scaling

    Jun 1, 2021, 00:00

  • Diabetes/Endocrine/Metabolic Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • PSU16 Trends in the Adoption of Different Surgical Approaches across Specialties: A National Study from 2013 to 2019

    Jun 1, 2021, 00:00

  • PCN38 A Literature Review Of Recurrent Or Metastatic Cervical Cancer Disease Burden, Treatment Outcomes, And Unmet Needs

    Jun 1, 2021, 00:00

  • PMU21 Factors Related to the Consumption of Antibiotics, a MIXED Methodology Study from the Post Conflicted Areas of SWAT Khyber-Pakhtunkhwa, Pakistan.

    Jun 1, 2021, 00:00

  • PRO27 Budget IMPACT Analysis of Pegvisomant in the Treatment Acromegaly in Colombia

    Jun 1, 2021, 00:00

  • PRO78 Real-World Treatment Patterns in Patients with Light Chain (AL) Amyloidosis: Analysis of the Optum US Electronic Health Records (EHR) and Commercial Claims Database

    Jun 1, 2021, 00:00

  • PMS10 Trends in Leaves Due to Long- and Short-Term Disability and Workers' Compensation for Employees with Back Pain in the United States

    Jun 1, 2021, 00:00

  • PNS26 Explaining Cognitive Impairment Among Adults with Chronic Pain: Non-Linear Decomposition Analysis of 2015 MEPS Data

    Jun 1, 2021, 00:00

  • PND49 An Assessment of Real-World Healthcare Provider Experiences with Insomnia Medications Focusing on Suvorexant in the United States (US)

    Jun 1, 2021, 00:00

  • PR3 Identifying Preferences for Closed-Loop Insulin Systems Among Children with Type 1 Diabetes and Their Parents: A Discrete Choice Experiment

    Jun 1, 2021, 00:00

  • PCN79 Healthcare Resource Utilization (HRU) of Immune Checkpoint Inhibitors in Metastatic LUNG Cancer Patients

    Jun 1, 2021, 00:00

  • PRO10 Indirect Treatment Comparison of Myalepta (Metreleptin) Compared to Best Supportive Care in Lipodystrophy

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Methodological Statistical Research

    Jun 1, 2021, 00:00

  • PDB35 Trajectory of Glycated Hemoglobin Over Time Among Obese Type 2 Diabetes Patients Prescribed U-100 Basal-only Insulin Regimens: A US Administrative Claims Data Analysis

    Jun 1, 2021, 00:00

  • Rare Public Health

    Jun 1, 2021, 00:00

  • PCN212 Age Disparities in Initial Surgery in Patients with Gliomas: A SEER Analysis

    Jun 1, 2021, 00:00

  • PCN134 Assessing the Relationship between Immature and Mature Overall Survival (OS) Outcomes on HTA Decision-Making: A Study of UK Nice Decisions and the Case for Coverage with Evidence Development

    Jun 1, 2021, 00:00

  • CO4 Predictors of Inpatient Relapse in Multiple Sclerosis Patients Using First-Line Disease Modifying Therapies: A Machine Learning Study of Real World Data

    Jun 1, 2021, 00:00

  • PNS61 The Second Coming of the Nice Appeal Process?

    Jun 1, 2021, 00:00

  • PNS25 Changing in Health Care Service Demand during the COVID-19 Pandemic in 2020: A Study Case of a Subsidized Health Care Company in the Caribbean Region of Colombia

    Jun 1, 2021, 00:00

  • PMU43 VALUE-Based Pricing in Colombia: The Devil Is in the Details

    Jun 1, 2021, 00:00

  • PRS10 Economic Evaluation of Umeclidinium/Vilanterol Versus Umeclidinium or Salmeterol in a UK COPD Population at Low Risk of Exacerbations Using the GALAXY Model

    Jun 1, 2021, 00:00

  • PMU49 Patient Heterogeneity and the Limitations of One-Size-Fits-All Value-Based Pricing: A Systematic Review and Future Directions

    Jun 1, 2021, 00:00

  • Surgery - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PND19 Healthcare Burden of Medication-Overuse Headache in Patients with Migraine

    Jun 1, 2021, 00:00

  • Health Technology Assessment Studies

    Jun 1, 2021, 00:00

  • Infectious Diseases - Patient-Centered Research

    Jun 1, 2021, 00:00

  • Expediting Patient Access to New Health Technologies: Role of Disease-Specific Reference Models

    Jun 1, 2021, 00:00

  • PIN56 Content Analysis of FDA Warning Letters for Fraudulent COVID-19 Claims Using the Economic, Clinical, Humanistic Outcomes (ECHO) MODEL

    Jun 1, 2021, 00:00

  • Medical Devices - Clinical Outcomes

    Jun 1, 2021, 00:00

  • ST3 Development of a Survey-Based Predictive Model for Clinical Dementia Rating in Alzheimer's Disease

    Jun 1, 2021, 00:00

  • PIH9 Cost-Effectiveness of Myomectomy VS. Hysterectomy in Women with Uterine Fibriods

    Jun 1, 2021, 00:00

  • PND41 Direct Medical Costs of Parkinson's Disease in JAPAN

    Jun 1, 2021, 00:00

  • PRO54 Humanistic Burden of Chronic Hypoparathyroidism - Results of a Systematic Literature Review

    Jun 1, 2021, 00:00

  • PSU11 Resource Utilization and Disaggregated Cost Analysis of Bariatric Surgery in the Australian Public Healthcare System

    Jun 1, 2021, 00:00

  • Patient Behavior Studies

    Jun 1, 2021, 00:00

  • PMU60 Assessing the Readability of Patient-Reported Outcome Measures in Trials for Drugs with Recent FDA Approval

    Jun 1, 2021, 00:00

  • Urinary/Kidney Disorders - Patient-Centered Research

    Jun 1, 2021, 00:00

  • Surgery - Epidemiology Public Health

    Jun 1, 2021, 00:00

  • PMU26 Changes in Schedule II Opioid Prescriptions Dispensed By Medicaid in Following ACUTE PAIN Opioid Restriction LAWS

    Jun 1, 2021, 00:00

  • PDG13 Healthcare Expenditures and Resource Utilization Among a Nationally Representative Population of Narcotic Users in the United States, 2008 to 2017

    Jun 1, 2021, 00:00

  • PCN37 An Oncology Real-World Data Assessment Framework for Outcomes Research

    Jun 1, 2021, 00:00

  • Systemic Disorders/Conditions - Clinical Outcomes

    Jun 1, 2021, 00:00

  • PCV24 A Threshold Analysis of the Cost-Effectiveness of Adjunctive Inclisiran Therapy for Ascvd Patients with LDL ≥70 MG/DL on Maximally Tolerated Statin Therapy

    Jun 1, 2021, 00:00

  • AI2 The Impact of Including Race and Ethnicity in Risk Prediction Models on Racial Bias

    Jun 1, 2021, 00:00

  • PIN81 Towards a Better Understanding of COVID-19 Among Young Adults Ages 18-24

    Jun 1, 2021, 00:00

  • PIT5 Cost Savings of Autologous Cell Harvesting Device for the Treatment of Burns Requiring Hospitalization: An Economic Evaluation Using Real-World DATA

    Jun 1, 2021, 00:00

  • PR4 Health Utility Assessment of Different Options for Treatment of Iron Deficiency Anemia: Results from Time-Trade-Off Study in China

    Jun 1, 2021, 00:00

  • PMH47 Medication Use Patterns Among Adult Mhealth Users with ADHD

    Jun 1, 2021, 00:00

  • PMD6 Procedure Cost-Comparison Analysis of Liquid Embolic System Techniques Using EVOH and n-BCA in the Embolization of Brain Arteriovenous Malformations

    Jun 1, 2021, 00:00

  • PMU71 Real World Data Availability in Latin America: Assessment and Implications for Research and Healthcare Decision Making

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • PDB15 Cost-Effectiveness of a NOVEL Treatment for Diabetic Foot Ulcer Among Patients with Diabetes: A Modeling Study

    Jun 1, 2021, 00:00

  • Award Winners

    Jun 1, 2021, 00:00

  • ML4 Association of Incident Cancer with Low-Value Care among Elderly Medicare Beneficiaries Using Machine Learning

    Jun 1, 2021, 00:00

  • PCN85 Real-World Treatment Patterns and Healthcare Costs Among Patients With Muscle-Invasive Urothelial Carcinoma Undergoing Radical Surgery in MarketScan Databases

    Jun 1, 2021, 00:00

  • Gastrointestinal Disorders - Economic Evaluation

    Jun 1, 2021, 00:00

  • PMH14 Association between Substance Use Disorder and Mental Health Service Utilization Among Adults with Major Depressive Disorder Using the National Survey on Drug Use and Health

    Jun 1, 2021, 00:00

  • PUK2 Hospitalization in Patients Receiving Maintenance Dialysis with Hyperphosphatemia Randomized to Tenapanor or Sevelamer

    Jun 1, 2021, 00:00

  • PCV18 Implementation of Pharmacogenomic Clinical Decision Support Alerts in Learning Health Systems: A Cost-Utility Analysis

    Jun 1, 2021, 00:00

  • PNS33 Recommendations for the Design and Implementation of an Early Feasibility Studies Program in Italy

    Jun 1, 2021, 00:00

  • PNS106 Quality of Life Evaluation in the UK General Population Using the Pedsql Questionnaire

    Jun 1, 2021, 00:00

  • PNS46 Development of Consumer-Reported Outcome Measure (CROM) Standards for the Tobacco Industry with Respect to Psychometric CROM Using a Consortium-Based Approach: Methodology and Scope

    Jun 1, 2021, 00:00

  • Respiratory-Related Disorders - Health Technology Assessment

    Jun 1, 2021, 00:00

  • PND14 Expanding the Components of Economic Analyses of Pharmacotherapy for Parkinson's Disease

    Jun 1, 2021, 00:00

  • PCN31 Matching Adjusted Indirect Treatment Comparison of FGFR2+ Patients in the FIGHT-202 Trial vs. Patients with Unspecified FGFR2 Status Receiving Standard of Care Treatments

    Jun 1, 2021, 00:00

  • PCV20 Cost-Effectiveness of a Tacrolimus-Mycophenolate Mofetil Regimen for Organ Rejection Prophylaxis in Heart Transplant Recipients in Colombia

    Jun 1, 2021, 00:00

  • PMU28 Association between Social Determinants of Health and Depression Among Patients with Psoriasis in the US

    Jun 1, 2021, 00:00

  • PCN160 Potential Impact of Advanced Therapy Medicinal Products on Irish Hematology-Oncology Care Pathway

    Jun 1, 2021, 00:00

  • PCV12 The Economic Burden of out-of-Hospital Cardiac Arrest Increases with Severity of Prognosis Among US Medicare Older Adults (2017-2019)

    Jun 1, 2021, 00:00

  • PRO53 Symptoms and impact of aromatic l-amino acid decarboxylase deficiency (AADCd): A qualitative study

    Jun 1, 2021, 00:00

  • Multiple Diseases - Health Policy Regulatory

    Jun 1, 2021, 00:00

  • PGI13 Economic Burden Associated with Strictures and/or Fistulae Among Commercially Insured Patients Diagnosed with Crohn?s Disease in the US

    Jun 1, 2021, 00:00

  • PMH42 Early Improvements in Functioning and Quality of Life with AXS-05 in Major Depressive Disorder: Resultsfrom the GEMINI Trial

    Jun 1, 2021, 00:00

  • PGI9 Using a New Powered Stapling System with Gripping Surface Technology Is Associated with Better Intraoperative Outcomes Among Patients with Gastric Carcinoma

    Jun 1, 2021, 00:00

  • PDB34 Comparative Efficacy and Safety of Avatrombopag Versus Lusutrombopag in Patients with Chronic LIVER Disease and Severe Thrombocytopenia Undergoing Invasive Procedures: A Systematic Literature Review and Network Meta-Analysis

    Jun 1, 2021, 00:00

  • No Specific Disease - Medical Technologies

    Jun 1, 2021, 00:00

  • PBI9 The TOTAL Medical Expenditure and out-of-Pocket Expenditure of Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis Patients in the United States

    Jun 1, 2021, 00:00

  • PNS48 Do US Commercial Health Plans Cite ICER Reports in Their Specialty Drug Coverage Policies? an Empirical Analysis

    Jun 1, 2021, 00:00

  • PIH24 Medical Home Implementation Reduced Inappropriate Medication Use Among Older Adults in Parma, Italy: Does Early Adoption and Duration of Experience Matter?

    Jun 1, 2021, 00:00

  • PNS30 The Humanistic and Economic Costs of Conversion Therapy: A Systematic Literature Review

    Jun 1, 2021, 00:00

  • PND50 Patterns of Home Health Care Use and Associated Costs in Elderly with Alzheimer's Disease and Related Dementias

    Jun 1, 2021, 00:00

  • PNS115 Real World Evidence to Support Regulatory Decisions: Frameworks for Latin American Agencies

    Jun 1, 2021, 00:00

  • PRO58 Beyond Color Blindness: The Patient and Societal IMPACT of Photoaversion and Vision Loss Associated with Achromatopsia

    Jun 1, 2021, 00:00
  • «
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46 (current)
  • 47
  • 48
  • 49
  • 50
  • »